Gene-edited pigs approved for consumption by Health Canada
In a significant development that could change the landscape of agriculture and food production, Health Canada has confirmed that pork products derived from genetically modified pigs, specifically designed to resist a damaging porcine virus, pose no safety risks and are just as nutritious as traditional pork available in stores.
On January 23, 2026, federal health authorities declared that pigs resistant to the porcine reproductive and respiratory syndrome viruses (PRRSV)—a group of viruses known to wreak havoc on pig populations—are safe for inclusion in both human food and animal feed. This announcement comes as companies from Canada and the United Kingdom have sought approval to introduce these innovative products into the marketplace.
Among the companies involved are Genus PLC, a UK-based firm specializing in top-tier genetics for livestock, and PIC Canada Ltd., based in Winnipeg. Both have engaged with Health Canada and the Canadian Food Inspection Agency to facilitate the commercialization of these gene-edited pigs as food sources.
Health Canada emphasized that enhancing resistance to PRRSV in pigs will not only protect livestock from illness but also help to reduce the need for antibiotics, thus supporting better animal welfare. Furthermore, it aims to contribute to a more stable, cost-effective, and sustainable food supply chain.
Interestingly, Genus PLC's virus-resistant pigs are already authorized for sale in several countries, including the U.S., Brazil, Colombia, and the Dominican Republic. However, the company plans to wait for regulatory approval in additional key markets before initiating any sales in Canada. In a reassuring note, Health Canada stated, "As there were no health or safety concerns identified, foods sourced from these PRRSV-resistant pigs do not require special labeling."
The conversation around genetically modified organisms (GMOs) is not new. Over 25 years ago, scientists at Memorial University in Newfoundland developed AquAdvantage Salmon, which became Canada's first authorized transgenic food animal. This salmon, engineered by introducing DNA from Pacific salmon and ocean pout, faced scrutiny from organizations like the Council of Canadians concerning environmental impacts and resource usage.
Unlike AquAdvantage Salmon, which involved interspecies genetic modification, the PRRSV-resistant pigs were created using CRISPR technology. This advanced method allows for precise edits to the genetic code without incorporating foreign genetic material, according to researchers.
Gwendolyn Blue, a professor at the University of Calgary who specializes in the political and ethical implications of gene editing, remarked, "This is the first instance of a gene-edited animal being approved for commercial sale in Canada." While she acknowledges the potential benefits of these PRRSV-resistant pigs, she also points out that this approval raises important ethical, moral, cultural, and political discussions amid evolving biotechnology regulations in Canada.
To develop pigs resistant to PRRS, Genus PLC effectively eliminated a segment of a specific gene that the PRRS virus utilizes to infiltrate and infect the animal.
Moreover, CRISPR technology is not confined to agricultural applications; it has made strides in medicine as well. In an inspiring case from 2025, U.S. doctors personalized gene therapy using CRISPR for a baby suffering from a rare and severe genetic disorder. Additionally, in 2023, Britain's medical authority sanctioned the world’s first gene therapy specifically targeting sickle cell disease and thalassemia, conditions stemming from genetic mutations that affect hemoglobin in red blood cells.
As we witness these advancements, it prompts us to consider: What are the broader implications of gene-edited animals in our food supply? Are we prepared to embrace these innovations, or do they raise too many ethical concerns? Feel free to share your thoughts and opinions in the comments.
